Skip to main content

Silexion Therapeutics Corp 8-K, filed Oct 26, 2026

Silexion Therapeutics Corp (SLXN)

8-K 2026-10-26 For: 2026-10-26
View Original
Added on October 26, 2026

About this 8-K

Silexion Therapeutics Corp filed this 8-K on October 26, 2026.

Silexion Therapeutics shareholders approved increasing authorized share capital by 500,000,000 ordinary shares, to 515,900,000, and a reverse split range of 1-for-15 to 1-for-25, with the Board setting 1-for-24. AI summary

Items reported

  • Item 5.03: Charter or bylaw amendment, or fiscal year change
  • Item 5.07: Shareholder vote results
  • Item 9.01: Financial statements and exhibits